- Q1 2024 VolitionRX Ltd Earnings Call TranscriptMay 14, 2024$0.75 (-14.53%)Earnings
- Q4 2023 VolitionRX Ltd Earnings Call TranscriptMar 26, 2024$0.7498 (+4.14%)Earnings
- VolitionRX Ltd Data Insights Webinar TranscriptOct 26, 2023
- VolitionRX Ltd at LD Micro Main Event XVI Conference TranscriptOct 04, 2023
- Q2 2023 VolitionRX Ltd Earnings Call TranscriptAug 15, 2023$1.21 (-1.63%)Earnings
- VolitionRX Ltd Capital Market Day TranscriptMay 11, 2023
- Q1 2023 VolitionRX Ltd Earnings Call TranscriptMay 11, 2023$1.89 (-1.05%)Earnings
- Q4 2022 VolitionRX Ltd Earnings Call TranscriptMar 16, 2023$1.72 (+11.69%)Earnings
- VolitionRX Ltd at OTC Markets Life Science Investor Forum (Virtual) TranscriptMar 09, 2023
- VolitionRX Ltd at Sidoti & Company January Micro-Cap Virtual Conference TranscriptJan 19, 2023
- VolitionRX Ltd at Issuer Direct Planet MicroCap Showcase (Virtual) TranscriptDec 07, 2022
- Q3 2022 VolitionRX Ltd Earnings Call TranscriptNov 15, 2022$1.76 (+6.02%)Earnings
- VolitionRX Ltd at OTC Markets Life Sciences Investor Forum TranscriptSep 15, 2022
- Q2 2022 VolitionRX Ltd Earnings Call TranscriptAug 11, 2022$2.02Earnings
- Q1 2022 VolitionRX Ltd Earnings Call TranscriptMay 12, 2022$2.11 (-9.83%)Earnings
- Q4 2021 VolitionRX Ltd Earnings Call TranscriptMar 31, 2022$3.01 (-7.10%)Earnings
- Q3 2021 VolitionRX Ltd Earnings Call TranscriptNov 11, 2021$3.68 (+2.22%)Earnings
- VolitionRX Ltd at SNN Network Summer Event (Virtual) TranscriptAug 18, 2021
- Q2 2021 VolitionRX Ltd Earnings and Business Update Call TranscriptAug 12, 2021
- Q1 2021 VolitionRX Ltd Earnings Call TranscriptMay 12, 2021$3.16 (+0.96%)Earnings
- Q3 2020 VolitionRX Ltd Earnings Call TranscriptNov 13, 2020$3.46 (+7.45%)Earnings
- VolitionRx Limited Presentation at the Rocky Mountain Microcap Conference VI TranscriptNov 13, 2020
- VolitionRX Ltd To Provide Corporate Update TranscriptOct 14, 2020
- VolitionRX Ltd To Present At GCFF TranscriptSep 10, 2020
- VolitionRX Ltd At SNN Network TranscriptAug 19, 2020
- Q1 2020 VolitionRX Ltd Earnings Call TranscriptMay 08, 2020$4.16 (-0.72%)Earnings
- VolitionRx Ltd. Webcast SNN Network TranscriptApr 29, 2020
- Q4 2019 VolitionRX Ltd Earnings Call TranscriptFeb 21, 2020$4.57 (-8.23%)Earnings
- Q3 2019 VolitionRX Ltd Earnings Call TranscriptNov 13, 2019$5.36 (+3.28%)Earnings
VolitionRX Ltd To Present At GCFF Transcript
We are VolitionRX. Ticker is BNRX on the New York Stock Exchange, American Stock Exchange. I will be making some forward-looking statements. So I do point you to the forward-looking statements and disclaimer. And a little bit about Volition. Volition is simple. We want to save lives.
We are a diagnostics company, developing blood tests to screen primarily for different cancer types. But As Gilbert mentioned, we are also developing a blood test for a noncancer indication [of] COVID-19. And I'll talk a little bit about that product because the coronavirus is front and center for most of us these days.
So here, you can see a little bit about our COVID-19 product development, developing a blood tests for this particular virus. We are not developing a frontline blood test for the coronavirus. There are a number of FDA approved frontline screens for the coronavirus already in use in the United States.
What we are planning to develop is a triage or a risk stratification blood test to be given to patients who have had a
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)